ResMed Inc. RMD
$229.94
-9.05%
at last close
Market Cap$32.34 billion
P/E Ratio—
Div Yield1.15%
Volume3.47M
52-Week Range
$180.26$284.87
Analyst Ratings
- Consensus
- Hold — 4 Buy · 9 Hold · 0 Sell (13 analysts)
- Avg. Price Target
- $250.45 (+8.9% upside)
Key Stats
- Today's Range
- $228.33 – $248.04
- 50-Day Range
- $215.80 – $255.56
- 52-Week Range
- $180.26 – $284.87
- Volume
- 3.47 million shs
- Average Volume
- 1.17 million shs
- Market Cap
- $32.34 billion
- P/E Ratio
- —
- Dividend Yield
- 1.15%
Dividend
- Dividend Yield
- 1.15%
- Annual Dividend
- $2.64
- Payout Ratio
- —
- Ex-Dividend Date
- 2026-11-12
Short Interest
- Short Interest
- 4.14%
- Days to Cover
- 15.61
About ResMed Inc.
ResMed makes continuous positive airway pressure devices and the masks used to treat obstructive sleep apnea, a condition in which the airway repeatedly collapses during sleep. Devices make up about half of revenue, masks and accessories close to 40%, and residential care software the remainder. Growth depends on diagnosing more of the large untreated sleep apnea population and moving them onto therapy. The Americas contribute about two-thirds of device and mask revenue, with most of the rest from Europe, Japan, and Australia.
Related Stocks
Compare head-to-head: RMD vs SYK·RMD vs BSX·RMD vs GKOS·RMD vs BAX
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.